Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. The only way to get Ozempic online is through a prescription from a licensed ...

Ozempic (semaglutide) is a subcutaneous injection used in people with type 2 diabetes. It may cause mild side effects, such as abdominal pain, or more serious side effects, such as diabetic ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind. Several studies have linked the shots to conditions that cause inflammation and block blood ...

Ozempic has skyrocketed in popularity as both a diabetes medication and a weight loss aid, but a growing number of patients are reporting an unexpected and puzzling side effect. Some users have ...

He also published one of the first case series that found semaglutide, the active ingredient in Ozempic, to effectively reduce alcohol consumption among six people with addiction. (The drug ...

Our editors also may be in touch with follow-up questions. Ozempic is a brand-name, injectable semaglutide medication. It’s prescribed, alongside dietary changes and exercise, to adults with ...

Ozempic (semaglutide) is a brand-name drug prescribed to treat certain conditions, such as type 2 diabetes. Ozempic has interactions with some other drugs, such as insulin, and certain supplements ...

You may take Ozempic or another drug to control your diabetes or lose weight, but these so-called GLP-1s also have a host of other effects ‒ some good and some not so good. A new study ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...